Opinions expressed by Entrepreneur contributors are their own.
Elon Musk expects to start human clinical trials for his Neuralink wireless device in six months.
Using brain chips, the company wants to enable disabled patients to move and communicate again. As it seeks U.S. regulatory approval for clinical trials in people, Neuralink has been testing on animals in San Francisco and Texas.
Musk said the company wants “to be extremely careful and certain” the chip “will work well before putting a device into a human.”
“But,” he said, “we’ve submitted, I think, most of our paperwork to the FDA, and probably
→ Continue reading at Entrepreneur